Pfizer agreed to pay 2.3 billion dollars, the largest in DOJ history, in a settlement with the Justice Department in 2009. $1.195 billion of that settlement is for the ‘intent to defraud or mislead’ the public with an anti-inflammatory drug Bextra that was discontinued in 2005. Pfzier intentionally marketed the drug for off-label purposes and unapproved dosages by the FDA. Pfizer also agreed to pay 1 billion dollars in response to the False Claims Act for illegally promoting four other drugs and paying ‘kickbacks’ to health care providers that prescribed them.
In addition, Pfizer has agreed to pay $1 billion to resolve allegations under the civil False Claims Act that the company illegally promoted four drugs – Bextra; Geodon, an anti-psychotic drug; Zyvox, an antibiotic; and Lyrica, an anti-epileptic drug – and caused false claims to be submitted to government health care programs for uses that were not medically accepted indications and therefore not covered by those programs. The civil settlement also resolves allegations that Pfizer paid kickbacks to health care providers to induce them to prescribe these, as well as other, drugs.